1. PhRMA perspective on population and individual bioequivalence;Barrett;Journal of Clinical Pharmacology,2000
2. US Code of Federal Regulations. (2000). Bioavailability and bioequivalence requirements. US Government Printing Office, Washington, DC, Vol. 21, Part 320.
3. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products—general considerations,2003
4. Guidance for industry: topical dermatologic corticosteroids: In vivo bioequivalence,1995
5. Bioavailability and bioequivalence;Tandon,2002